Although the hormones GLP-1 and GIP, as well as their receptors, are closely related, GIP receptor (GIPR) activation seems to be devoid of these actions
Testing transparency Third-party testing information is referenced but provides limited batch traceability and lacks consistent, clearly accessible verification details
Diabetes Care 42(12):22622271 Funding This research was supported by the Industrial Strategic Technology Development Program (20018218, Development of oral drug formulation technology and process technology based on continuous process and RS-2023-00230559, Development of integrated solution technology for QbD-based continuous process) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea)
On average, GLP-1 use leads to a modest amount of weight loss, averaging between 5-10% of body weight, while some users may not experience any weight changes